The p53 gene is highly conserved (Soussi et al., 1987) and is regulatory for cell proliferation (Milner & Milner, 1981; Mercer et al., 1982; Reich & Levine, 1984) . In human colorectal carcinoma a tumour suppressor function for p53 is indicated, since progression to pre-malignant and malignant phases correlates with loss of wild type p53 (Baker et al., 1989) . Allelic degeneration of p53 is also strongly implicated in human carcinoma of the lung (Takahashi et al., 1989) . Mutation within the p53 gene can result in oncogenic activation and the mutant p53 can co-operate with ras in cell transformation (Hinds et al., 1989; Eliyahu et al., 1988) .
Experimental studies on p53 function have mainly involved the murine p53 protein for which monoclonal antibodies reactive with several discrete epitopes are available (see Yewdell et al., 1986) . Different transformed cell lines express immunological variants of p53, a given variant being characteristic for a given cell line (Milner & Cook, 1986) . In these studies it was noted that the monoclonal antibody PAb246 failed to react with p53 from spontaneously transformed and chemically transformed cells (Milner & Cook, 1986) . Subsequent studies have revealed that the epitope for PAb246 is lacking on activated mutants of the p53 protein (Hinds et al., 1989) .
We now present evidence that wild type p53 can adopt a conformation apparently identical to the mutant p53-246°p rotein. This discovery arose from studies on p53 expressed in vitro, using wild type p53 cDNA. The observation that wild type p53 protein can exist in two specfic configurations, pS3-246+ and p53-246°, raises the possibility that p53 may function as an allosteric protein in cell growth control. Using the monoclonal antibody PAb1620 (Milner et al., 1987) we also show that human p53 can exist in two specific configurations, analogous to p53-246+ and p53-246°of the murine p53 protein.
Materials and methods
Transcription and translation ofp53 cDNA An expression plasmid containing full length murine p53 cDNA, designated pSP65m53 (Jenkins et al., 1984) was transfected into E. coli, amplified and purified as detailed in Gamble and Milner (1988) . The plasmid was linearised with HindIll and aliquots containing 1.0fig cDNA il-' in double distilled water were stored at -20'C. The cDNA was transcribed using SP6 RNA polymerase and the purified p53 mRNA was stored as aliquots at -70'C. A second plasmid, encoding human p53, was also used. This plasmid, pSP65pS3H8, was constructed by V. Rotter using the human p53 cDNA clone H8 (Harris et al., 1986) . Transcription and translation were as for the murine p53 cDNA.
For translation in vitro L35S methionine (40.5 TBq mmol-', 555 MBq ml-', Amersham International plc) was added to mRNA dependent rabbit reticulocyte lysate to give a concentration of 5% v/v. To this was added 1/10 volume of p53 mRNA. Translations were carried out at 30°C, typically for 1 h, and stopped by chilling on ice.
Several batches of reticulocyte lysate were used. Each had been prepared according to the method of Pelham and Jackson (1976) and they were obtained from Dr Tim Hunt, Department of Biochemistry, Cambridge University. Working stocks of supplemented reticulocyte lysate (Hunt & Jackson, 1974) were stored as aliquots at -70°C. The different batches of reticulocyte lysate had been prepared at different times, but otherwise were essentially identical (Tim Hunt, personal communication).
Immunoprecipitations
For immunoprecipitation of p53 protein the reticulocyte lysate was diluted I in 100 with lysis buffer (10 mM Tris base; 0.14 M NaCl and 0.5% NP40 adjusted to pH 8.0) and 100 il aliquots were immunoprecipitated for I h on ice. Immune complexes were absorbed with 10tlI of 10% formalin-fixed Staphylococcus aureus (Kessler, 1975) , washed and eluted by boiling for 10 min in 50pl of sample buffer (Laemlli, 1970) .
The following anti-p53 monoclonal antibodies were used: PAb421 (Harlow et al., 1981) ; PAbl22 (Gurney et al., 1980) , RA3.2C2 (Coffman & Weissman, 1981; Rotter et al., 1980) ; PAb242, PAb246 and PAb248 (Yewdell et al., 1986) ; PAb200.47 (De Leo et al., 1979) ; PAbl620 (Milner et al., 1987) and PAb6O7 (Gooding, unpublished) .
Phosphorylation studies
The phosphorylation of p53 translated in reticulocyte lysate was studied using gamma 32P-ATP (222 TBq, 370 MB2 ml-'; Amersham International plc). Translation mixtures were prepared with either 35S-methionine or an equal volume of unlabelled methionine (1 mM) and to these were added either gamma 32P-ATP or water (1 in 2 vol/vol). (Figure 1 and Table I) . murine p53 and which also recognises human p53 (Milner et Meek & Eckhart, 1987) . Since the addition of one or more % mixture Figure 4 The immunology of p53 translated by mixtures of reticulocyte lysates type A and type B. Varying proportions of lysate types A and B were pre-mixed as indicated and p53 mRNA (I fil per 10 I mixed lysate) was added and translated in the presence of 35S-methionine at 30°C for I h. The translated product was immunoprecipitated and run out on SDS-PAGE (Materials and methods) and the amounts of "5S-labelled p53 immunoprecipitated with PAb246 relative to PAb421 were quantitated by scintillation counting (I ttl aliquots of immunoprecipitated p53) and by densitometry scanning of the autoradiographed gel. Dotted line indicates the level of background with B5, a negative control immunoprecipitation. _~~~~~~~~~~I I charged phosphate groups might affect the conformation of the p53 polypeptide we next tested the ability of reticulocyte lysate to phosphorylate p53 translated in vitro. The protein kinase activity of reticulocytes includes a component that is dependent upon cyclic AMP (cAMP) and accordingly the phosphorylation studies were carried out in the presence and absence of cAMP. Controls showed no effect of cAMP upon the conformation of p53 translated in vitro. The endogenous protein kinase activity of the reticulocyte lysate was high and multiple 32P-labelled proteins were detected after incubation with gamma 32P-ATP (not shown). Following immunoprecipitation with anti-p53 monoclonal antibodies, 32P-labelled p53 was clearly detectable (Figure 5a ). Lysates type A and type B both phosphorylated p53 in vitro.
The wild type p53 variants were indistinguishable by twodimensional gel electrophoresis ( Figure Sb) and by peptide mapping (not shown), consistent with p53-246 + and p53-246°r epresenting conformational variants of the full length p53 polypeptide. Full length p53 is also indicated by reactivity with monoclonal antibodies directed against epitopes that span the wild type p53 polypeptide (Table I and Figure 1 ).
Discussion
The functioning of p53 involves molecular interaction with specific target proteins. The first cellular target to be identified for wild type p53 is p34cdc2, a cell cycle control protein (Milner et al., submitted) .
The interaction between p53 and its target molecules will be determined in part by the conformation of the p53 polypeptide. For example p53-246+ has a high affinity for the large T antigen of simian virus 40 (SV40), whereas mutant p53-2460 fails to bind SV40 large T (Sturzbecher et al., 1987) . The wild type variant p53-246°also fails to bind SV40 large T (Milner & Cook, in preparation (Hinds et al., 1989; Baker et al., 1989; Takahashi et al., 1989) .
We now demonstrate that wild type murine p53 can be expressed in the form p53-2460. This observation was completely unexpected since, hitherto, p53-246°was believed to represent mutant p53. The results presented in this paper are for wild type p53 expressed in vitro: the same stock of p53 mRNA being translated into p53-246+ by lysate A and into p53-2460 by lysate B (Figure 1 , Table I tide in such a way as to destabilise p53 conformation associated with negative growth control. The availability of the monoclonal antibody PAbl620 allowed us to extend the above observations to human p53. PAb246 is species specific and does not recognise human p53. However, PAbl620 reacts with both murine and human p53 (Milner et al., 1987) . The PAbl620 and PAb246 epitopes are topologically related on murine p53 and they appear to be coupled in terms of their presence/absence on protein (Milner et al., 1987, see Tables I and II) . By extrapolation we predict that, for human p53, the PAbl620 epitope indicates wild type suppressor function. Moreover, activating mutations within the human p53 gene may yield p53-16200, analogous to p53-246°for activated mutants of the murine gene. Thus the epitope for PAbl620 has potential as marker for the wild type p53 anti-oncogene.
